PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
20-May-2025 OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit OKYO Pharma
20-May-2025 SISCAPA and Biognosys Announce Strategic Collaboration to Deliver End-to-End High-Sensitivity Targeted Protein Quantification Solutions Siscapa
20-May-2025 Transactions in Connection with Share Buy-back Program Genmab
20-May-2025 Cristcot Appoints Jenny Gizzi as Chief Administrative Officer Cristcot
20-May-2025 ABPI welcomes announcement of ten-year budgets for R&D funding ABPI
20-May-2025 Transforming healthcare engagement: Key strategies for 2025 and beyond CMI Media Group
20-May-2025 CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates CureVac
20-May-2025 Co-Lab-oration at its best as Lab Awards open for submission Lab Innovations
20-May-2025 Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference Zymeworks
20-May-2025 VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer Veraxa Biotech
20-May-2025 Poolbeg Pharma plc announces FY2024 Results and Proposed Fundraising to raise approximately £4.1 million Poolbeg Pharma PLC
20-May-2025 Xinnate Announces Successful FDA Meeting for TCP-25 Xinnate
20-May-2025 Actimed Therapeutics Announces New Programme to Investigate Potential Muscle Preservation Effects of S-pindolol Benzoate in Obese Patients Treated with GLP-1 Agonists Actimed Therapeutics
20-May-2025 Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study shows ESOC 2025
20-May-2025 Ancient DNA used to map evolution of fever-causing bacteria Francis Crick Institute
20-May-2025 CellProthera Selects CELLforCURE by SEQENS for Phase 3 GMP Manufacturing  CellProthera
20-May-2025 New platform launches to support people living with dementia and their carers DementiaNet
20-May-2025 Another Day Pharma announces promising Phase II results for topical post-prostatectomy erectile dysfunction treatment Another Day Pharma Ltd
20-May-2025 Kanceraprovides an update on the collaboration with Recardio Inc. and the company’s clinical development program Kancera
20-May-2025 Journal of Critical Care publishes positive results from prespecified, biomarker-guided subgroup analysis of AdrenoMed’s Phase II AdrenOSS-2 trial in septic shock AdrenoMed AG